drugset / Trial / NCT00201955
Study of Rebamipide Eye Drops to Treat Dry Eye
Phase 3
Completed
762 enrolled
Otsuka Pharmaceutical Development & Commercialization, Inc.
Novartis · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
Timeline
- Start
- 2004-05-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rebamipide | Small molecule | 1 % | Other |
| Comparator | Rebamipide | Small molecule | 2 % | Other |